[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fb39o82VJ2xNtnfevgfFqHv5yXZ4ixXh5V0Y6qnkYqwI":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":33,"phaseBuckets":34,"rows":41},"Norwegian Institute of Public Health",[4],51,false,12,0,8487865,49,[13,16,19,22,25,27,29,31],{"name":14,"count":15},"COVID-19",5,{"name":17,"count":18},"Breast Cancer",4,{"name":20,"count":21},"Respiratory Tract Infections",3,{"name":23,"count":24},"Covid19",2,{"name":26,"count":24},"Anxiety",{"name":28,"count":24},"Mild to Moderate Depression",{"name":30,"count":24},"Mental Health Wellness 1",{"name":32,"count":24},"Mental Disorders",[],[35,36,37,38,39,40],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[42,72,98],{"intervention":43,"totalTrials":44,"cells":45},"Boostrix polio",1,{"EARLY_PHASE1":46,"PHASE1":48,"PHASE2":50,"PHASE3":52,"PHASE4":54,"NA":70},{"trials":47,"activeCount":9},[],{"trials":49,"activeCount":9},[],{"trials":51,"activeCount":9},[],{"trials":53,"activeCount":9},[],{"trials":55,"activeCount":9},[56],{"nctId":57,"briefTitle":58,"status":59,"phases":60,"completion":61,"start":62,"enrollment":63,"conditions":64,"interventions":69},"NCT00514059","Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine","COMPLETED",[39],"2007-06","2007-04",83,[65,66,67,68],"Diphtheria","Tetanus","Pertussis","Polio",[43],{"trials":71,"activeCount":9},[],{"intervention":73,"totalTrials":44,"cells":74},"Hecolin",{"EARLY_PHASE1":75,"PHASE1":77,"PHASE2":79,"PHASE3":81,"PHASE4":83,"NA":96},{"trials":76,"activeCount":9},[],{"trials":78,"activeCount":9},[],{"trials":80,"activeCount":9},[],{"trials":82,"activeCount":9},[],{"trials":84,"activeCount":9},[85],{"nctId":86,"briefTitle":87,"status":59,"phases":88,"primaryCompletion":89,"completion":89,"start":90,"enrollment":91,"conditions":92,"interventions":94},"NCT02759991","Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.",[39],"2019-09-30","2017-10-02",19460,[93],"Hepatitis E Infection",[73,95],"Hepa-B",{"trials":97,"activeCount":9},[],{"intervention":95,"totalTrials":44,"cells":99},{"EARLY_PHASE1":100,"PHASE1":102,"PHASE2":104,"PHASE3":106,"PHASE4":108,"NA":114},{"trials":101,"activeCount":9},[],{"trials":103,"activeCount":9},[],{"trials":105,"activeCount":9},[],{"trials":107,"activeCount":9},[],{"trials":109,"activeCount":9},[110],{"nctId":86,"briefTitle":87,"status":59,"phases":111,"primaryCompletion":89,"completion":89,"start":90,"enrollment":91,"conditions":112,"interventions":113},[39],[93],[73,95],{"trials":115,"activeCount":9},[]]